Condition
Metabolic Encephalopathy
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting1
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06038513Not ApplicableTerminated
Transnasal Induction of Normothermia for Neurogenic Fever
NCT03535142Not ApplicableRecruiting
Prognostic Significance of Fatty Liver Disease in Bariatric Patients
NCT03360656Not ApplicableCompleted
Transnasal Induction of Normothermia in Febrile Stroke Patients
Showing all 3 trials